+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epilepsy Drug"

From
From
Refractory Epilepsy - Epidemiology Forecast to 2032 - Product Thumbnail Image

Refractory Epilepsy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Partial Epilepsy - Epidemiology Forecast to 2032 - Product Thumbnail Image

Partial Epilepsy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Drug Resistant Epilepsy - Epidemiology Forecast to 2032 - Product Thumbnail Image

Drug Resistant Epilepsy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2020 - Product Thumbnail Image

Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2020

  • Drug Pipelines
  • March 2020
  • 100 Pages
  • Global
From
From
Global Central Nervous System Therapeutic Market - Product Thumbnail Image

Global Central Nervous System Therapeutic Market

  • Report
  • May 2024
  • 200 Pages
From
Global Friedreich's Ataxia Market - Product Thumbnail Image

Global Friedreich's Ataxia Market

  • Report
  • May 2024
  • 200 Pages
From
Research Report on China's Levetiracetam Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Levetiracetam Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Epilepsy Forecast and Market Analysis to 2035 - Product Thumbnail Image

Epilepsy Forecast and Market Analysis to 2035

  • Drug Pipelines
  • July 2019
  • 345 Pages
  • Global
From
Global Epilepsy Drugs Market 2020-2024 - Product Thumbnail Image

Global Epilepsy Drugs Market 2020-2024

  • Report
  • November 2020
  • 120 Pages
  • Global
From
Global Pregabalin Market 2022-2026 - Product Thumbnail Image

Global Pregabalin Market 2022-2026

  • Report
  • September 2022
  • 120 Pages
  • Global
From
US Epilepsy Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Epilepsy Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
Loading Indicator

The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates. Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more